Thermo Fisher Scientific Reports Second Quarter 2019 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
Thermo Fisher Scientific (TMO) Tops Q2 EPS by 4c; Raises FY19 EPS/Revenue Guidance
July 24, 2019 6:07 AM EDTThermo Fisher Scientific (NYSE: TMO) reported Q2 EPS of $3.04, $0.04 better than the analyst estimate of $3.00. Revenue for the quarter came in at $6.32 billion versus the consensus estimate of $6.3 billion.
Second Quarter 2019 Highlights
Second quarter revenue increased 4% to $6.32 billion.Second quarter GAAP diluted earnings per share (EPS) increased 50% to $2.77.Second quarter adjusted EPS increased 11% to $3.04.Strengthened our mass spectrometry leadership with new instruments, workflows and software, highlighted by two new-generation Thermo Scientific Orbitrap systems the Exploris 480 and Eclipse Tribrid and a new workflow to advance biotherapeutics, called the HR Multi-Attribute Method.... More